(Q42992697)

12 November 2017

title

Amino acid substitutions in NS5A region of GB virus C and response to interferon therapy (English)

1 reference

12 November 2017

GB virus C

1 reference

Kato T

1

1 reference

12 November 2017

Mizokami M

2

1 reference

12 November 2017

Orito E

3

1 reference

12 November 2017

Ohba K

4

1 reference

12 November 2017

Nakano T

5

1 reference

12 November 2017

Kondo Y

6

1 reference

12 November 2017

Tanaka Y

7

1 reference

12 November 2017

Ueda R

8

1 reference

12 November 2017

Mukaide M

9

1 reference

12 November 2017

Yasuda K

10

1 reference

12 November 2017

Iino S

11

1 reference

12 November 2017

publication date

1 April 1999

1 reference

Journal of Medical Virology

12 November 2017

published in

1 reference

12 November 2017

volume

57

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

376-382

1 reference

Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

High prevalence of GB virus C/hepatitis G virus infection among the Jewish population in Uzbekistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Deletion analysis of GAL4 defines two transcriptional activating segments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Sequence heterogeneity within the 5'-terminal region of the hepatitis GB virus C genome and evidence for genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Three different GB virus C/hepatitis G virus genotypes. Phylogenetic analysis and a genotyping assay based on restriction fragment length polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Evolutionary relationship of hepatitis C, pesti-, flavi-, plantviruses, and newly discovered GB hepatitis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Interferon-alpha therapy in patients dually infected with hepatitis C virus and GB virus C/hepatitis G virus--virological response of HGV and pretreatment HGV viremia level

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Genetic diversity between hepatitis G virus isolates: analysis of nucleotide variation in the NS-3 and putative 'core' peptide genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Isolation of novel virus-like sequences associated with human hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Effect of hepatitis G virus infection on chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Genetic heterogeneity of hepatitis G virus isolates from different parts of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

Effect of interferon on GB virus C and hepatitis C virus in hepatitis patients with the co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C376%3A%3AAID-JMV9%3E3.0.CO%3B2-%23

10.1002/(SICI)1096-9071(199904)57:4<376::AID-JMV9>3.0.CO;2-#

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference